Skip to main content
Fig. 5 | Cancer Cell International

Fig. 5

From: Quantification of fibrinogen-to-pre-albumin ratio provides an integrating parameter for differential diagnosis and risk stratification of early-stage colorectal cancer

Fig. 5

Circulating FPR, chemotherapy, and prognosis of early-stage CRC. A, B FPR comparisons between stage I CRC patients with or without recurrence/death; C, D Recurrence and death rates of CT- and non-CT-treated stage II CRC patients with 20.0 ≥ FPR > 15 (a: CT-treated patients; c: non-CT-treated patients), or FPR > 20 (b: CT-treated patients; d: non-CT-treated patients) and FPR ≤ 15 (e: CT-treated patients; f: non-CT-treated patients); E The therapeutic selection according to circulating FPR. **p < 0.01; ns no significance

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us